FOXO TECHNOLOGIES INC. 8-K
Research Summary
AI-generated summary
FOXO Technologies CFO Resigns; Celene Grant Appointed
What Happened
FOXO Technologies (FOXO) announced in an 8-K that Chief Financial Officer Sylwia Nowak Hauman resigned effective March 18, 2026. Ms. Hauman’s resignation letter raised concerns about the company’s internal control environment, financial reporting processes, and finance-team resourcing; the Company expressly disagrees with those characterizations and says its internal controls and reporting processes have been significantly improved. On March 24, 2026, FOXO appointed Celene Laurene Rattray Grant (age 44) as its new CFO. Ms. Grant is a Certified Public Accountant with over 15 years of finance and healthcare industry experience and has previously supported the company as a consultant; she will receive a $200,000 annual base salary and be eligible for a discretionary annual bonus up to $25,000.
Key Details
- Resignation date: Sylwia Nowak Hauman resigned March 18, 2026.
- Appointment date: Celene Rattray Grant appointed CFO on March 24, 2026.
- Compensation: Ms. Grant’s base salary $200,000 and discretionary bonus up to $25,000.
- Background & SEC work: Ms. Grant is a CPA, B.S. in Accounting (Florida Atlantic University), MBA (Nova Southeastern). She served as a consultant to FOXO’s predecessor (Apr 2018–Jun 2021), was Chief Accounting Officer at Certified Foot and Ankle Specialists (Jun 2021–Feb 2024), returned to FOXO as consultant (Apr 2024–Nov 2025) helping restore SEC reporting standing, and most recently worked on SEC compliance at Rennova Health (Nov 2025–Mar 2026). The company states there are no family relationships or transactions requiring Item 404(a) disclosure.
Why It Matters
A CFO change is material because the CFO oversees financial reporting and internal controls. The resignation letter flagged concerns about controls and resourcing, while the company says those issues have been addressed and commits to filing its upcoming Form 10-K on time. Investors should watch the company's forthcoming 10-K and any additional disclosures about internal controls or restatements for further detail on the financial reporting outlook.
Loading document...